Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35


Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats.

Rao KN, Sentir AM, Engleman EA, Bell RL, Hulvershorn LA, Breier A, Chambers RA.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3933-3945. Epub 2016 Sep 17.


Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders.

Akerman SC, Brunette MF, Noordsy DL, Green AI.

Curr Addict Rep. 2014 Dec;1(4):251-260. Epub 2014 Sep 27.


Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamster.

Khokhar JY, Green AI.

Neuropharmacology. 2016 Jun;105:25-34. doi: 10.1016/j.neuropharm.2016.01.017. Epub 2016 Jan 12.


Desipramine enhances the ability of paliperidone to decrease alcohol drinking.

Chau DT, Khokhar JY, Gulick D, Dawson R, Green AI.

J Psychiatr Res. 2015 Oct;69:9-18. doi: 10.1016/j.jpsychires.2015.07.010. Epub 2015 Jul 18.


Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan.

Khokhar JY, Chau DT, Dawson R, Green AI.

Drug Alcohol Depend. 2015 Jul 1;152:277-81. doi: 10.1016/j.drugalcdep.2015.04.003. Epub 2015 Apr 22.


Prevalence and socio-demographic risk factors associated with psychoactive substance use in psychiatric out-patients of a tertiary hospital in Nigeria.

Okpataku CI, Kwanashie HO, Ejiofor JI, Olisah VO.

Niger Med J. 2014 Nov;55(6):460-4. doi: 10.4103/0300-1652.144695.


Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles.

Baltzley S, Mohammad A, Malkawi AH, Al-Ghananeem AM.

AAPS PharmSciTech. 2014 Dec;15(6):1598-602. doi: 10.1208/s12249-014-0189-5. Epub 2014 Aug 21.


Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster.

Gulick D, Chau DT, Khokhar JY, Dawson R, Green AI.

Psychiatry Res. 2014 Aug 30;218(3):329-34. doi: 10.1016/j.psychres.2014.04.038. Epub 2014 May 4.


Substance use in clinical high risk for psychosis: a review of the literature.

Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS.

Early Interv Psychiatry. 2014 May;8(2):104-12. doi: 10.1111/eip.12100. Epub 2013 Nov 14. Review.


A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders.

Petry NM, Alessi SM, Rash CJ.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):234-7. doi: 10.1016/j.drugalcdep.2012.10.017. Epub 2012 Nov 20.


Cannabis withdrawal in chronic cannabis users with schizophrenia.

Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner H, Schroeder JR, McMahon RP, Gorelick DA.

J Psychiatr Res. 2013 Feb;47(2):240-5. doi: 10.1016/j.jpsychires.2012.10.010. Epub 2012 Nov 10.


Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.

Bédard AM, Maheux J, Lévesque D, Samaha AN.

Schizophr Bull. 2013 May;39(3):692-702. doi: 10.1093/schbul/sbs077. Epub 2012 Aug 27.


Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.

Alene M, Wiese MD, Angamo MT, Bajorek BV, Yesuf EA, Wabe NT.

BMC Clin Pharmacol. 2012 Jun 18;12:10. doi: 10.1186/1472-6904-12-10.


Illicit drug use in heavy smokers with and without schizophrenia.

Mackowick KM, Heishman SJ, Wehring HJ, Liu F, McMahon RP, Kelly DL.

Schizophr Res. 2012 Aug;139(1-3):194-200. doi: 10.1016/j.schres.2012.04.012. Epub 2012 May 14.


Poor response to treatment: beyond medication.

Carvajal C.

Dialogues Clin Neurosci. 2004 Mar;6(1):93-103.


Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues.

Bédard AM, Maheux J, Lévesque D, Samaha AN.

Neuropsychopharmacology. 2011 May;36(6):1248-59. doi: 10.1038/npp.2011.10. Epub 2011 Feb 16.


Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters.

Chau DT, Gulick D, Xie H, Dawson R, Green AI.

Neuropharmacology. 2010 Feb;58(2):351-6. doi: 10.1016/j.neuropharm.2009.10.006. Epub 2009 Nov 4.


Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.

Bennett ME, Bellack AS, Brown CH, DiClemente C.

Addict Behav. 2009 Oct;34(10):806-14. doi: 10.1016/j.addbeh.2009.03.023. Epub 2009 Mar 27.


Changes over time and disparities in schizophrenia treatment quality.

Busch AB, Lehman AF, Goldman H, Frank RG.

Med Care. 2009 Feb;47(2):199-207. doi: 10.1097/MLR.0b013e31818475b7.

Supplemental Content

Support Center